New listings welcomed amongst COVID backdrop
Medicines Australia welcomes Friday’s announcement by Minister for Health the hon Greg Hunt on the PBS listing of breakthrough treatments for cardiovascular disease, rheumatoid arthritis and asthma from May 1.
Medicines Australia further acknowledges Minister Hunt’s commitment, on behalf of the Australian Government, to ensure Australians continue to access the vital medicines they need and importantly introduce innovative, breakthrough therapies to priority disease areas.
“There has been a significant focus on the COVID-19 health emergency and those affected by the virus, together with supporting the health of Australians living with chronic conditions in our community,” states Elizabeth de Somer, Chief Executive Officer, Medicines Australia.
“We appreciate the priority the Government is placing on the health of Australians and how a healthy community will help to support the economy – particularly in our recovery road-out of COVID-19,” adds Ms de Somer.
“Balancing the expenditure of the pandemic response while maintaining momentum and advancing treatment options and health delivery is essential.
“The medicines included in today’s PBS listing announcement will provide much needed treatments for some of the most vulnerable in our community,” she said.
Ends –
More information – Natalie Wimmer – nwimmer@medaus.com.au – 0450 728 660